Meldrum D R, Ayala A, Chaudry I H
Department of Surgery, Michigan State University, East Lansing 48824.
J Surg Res. 1994 Jun;56(6):537-42. doi: 10.1006/jsre.1994.1086.
Although it is known that decreased high-energy phosphates contribute to organ dysfunction following shock, it remains unknown whether changes in lymphocyte energetics contribute to the profound immune dysfunction that occurs in late septic shock. Moreover, while studies have shown that ATP-MgCl2 treatment after hemorrhagic shock improves tissue ATP levels and organ function, it remains unknown whether lymphocyte high-energy phosphates and immune functions are similarly affected by this agent after sepsis. To study this, sepsis was induced in C3H/HeN (endotoxin sensitive) mice by cecal ligation and puncture (CLP) and they were then treated intraperitoneally with ATP-MgCl2 or saline vehicle. Sham animals received laparotomy, but not CLP. Splenic lymphocytes were harvested 24 hr after treatment and ATP levels were determined by ultraresolution 31P NMR. Lymphocyte proliferative capacity was determined by [3H]-thymidine incorporation following mitogenic stimulation. Host survival was assessed following CLP with and without ATP-MgCl2 treatment. Prolonged sepsis caused a significant decrease (decreases 67 +/- 12% vs Sham) in lymphocyte ATP levels which were correlated with decreased lymphocyte proliferative capacity in response to mitogenic stimulation (64 +/- 17 x 10(3) vs. 232 +/- 43 x 10(3) counts per minute (cpm) in Sham; P < 0.05). Treatment with ATP-MgCl2 at the onset of sepsis significantly increased lymphocyte ATP levels (increases 32 +/- 15% vs CLP) and proliferative response to mitogenic stimuli (218 +/- 37 x 10(3) cpm, CLP/ATP-MgCl2; P < 0.05). Improved lymphocyte function in this group correlated with a significant increase in overall survival (20% CLP vs 70% CLP/ATP-MgCl2; P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
尽管已知高能磷酸盐减少会导致休克后器官功能障碍障碍,但,但尚不清楚淋巴细胞能量代谢的变化是否会导致晚期脓毒症休克中出现的严重免疫功能障碍。此外,虽然研究表明失血性休克后用ATP-MgCl2治疗可提高组织ATP水平和器官功能,但脓毒症后该药物是否同样会影响淋巴细胞高能磷酸盐和免疫功能仍不清楚。为了研究这一点,通过盲肠结扎和穿刺(CLP)在C3H/HeN(对内毒素敏感)小鼠中诱导脓毒症,然后腹腔注射ATP-MgCl2或生理盐水。假手术动物接受剖腹手术,但不进行CLP。治疗24小时后收集脾淋巴细胞,通过超分辨率31P NMR测定ATP水平。通过有丝分裂原刺激后[3H]-胸苷掺入来测定淋巴细胞增殖能力。评估有无ATP-MgCl2治疗的CLP后的宿主存活率。长时间的脓毒症导致淋巴细胞ATP水平显著降低(与假手术组相比降低67±12%),这与有丝分裂原刺激后淋巴细胞增殖能力降低相关(假手术组为232±43×10(3) 计数每分钟(cpm),而脓毒症组为64±17×10(3);P<0.05)。脓毒症发作时用ATP-MgCl2治疗可显著提高淋巴细胞ATP水平(与CLP组相比增加32±15%)和对有丝分裂原刺激的增殖反应(CLP/ATP-MgCl2组为218±37×10(3) cpm;P<0.05)。该组淋巴细胞功能的改善与总体存活率的显著提高相关(CLP组为20%,CLP/ATP-MgCl2组为70%;P<0.05)。(摘要截断于250字)